title: Response to Comment on Shahraz et al. Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A1c Targets? Diabetes Care 2016;38: e145-e146.
authors.affiliation: Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA ssharaz@tuftsmedicalcenter.org.
authors.forename: Saeid
authors.initials: S
authors.lastname: Shahraz
authors.affiliation: Division of Endocrinology, Tufts Medical Center, Boston, MA.
authors.forename: Anastassios G
authors.initials: AG
authors.lastname: Pittas
authors.affiliation: Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Lundquist
authors.affiliation: Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA.
authors.forename: Goodarz
authors.initials: G
authors.lastname: Danaei
authors.affiliation: Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA.
authors.forename: David M
authors.initials: DM
authors.lastname: Kent
mesh_terms: D003920:Diabetes Mellitus; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D006943:Hyperglycemia
chemical_list: D006442:Glycated Hemoglobin